F
Acorda Therapeutics, Inc. ACORQ
OTC PK
Recommendation
--
Prev Close
$0.0135
Volume
--
Avg Vol (90D)
0
Market Cap
--
Dividend & Yield
--
52-Week Range
$0.0132 - $2.40
P/E (TTM)
--
EPS (TTM)
-$212.10
My Lists My Alerts
Rating
Reward
--
--
Risk
--
--
Rating Factors
Growth Index
--
Efficiency Index
--
Solvency Index
--
Total Return Index
--
Volatility Index
--
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$115.66M
EBITDA (TTM)
$551.00K
EBIT (TTM)
-$24.08M
Net Income (TTM)
-$263.43M
Balance Sheet
Total Assets (Q)
$81.58M
Total Debt (Q)
$195.92M
Total Liabilities (Q)
$267.35M
Book Value Per Share (Q)
-$149.56
Cash Flow
Cash from Operations (TTM)
-$27.15M
Cash from Investing (TTM)
-$264.00K
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
-$27.42M
Filings
Filing Date
Tuesday, May 14, 2024
Period Date
Sunday, March 31, 2024
Next Filing
(est)
Price History
Loading...
Beta
1.05
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
0.00%
90-Day Total Return
0.00%
Year to Date Total Return
0.00%
1-Year Total Return
-99.32%
2-Year Total Return
-99.88%
3-Year Total Return
-99.96%
5-Year Total Return
-99.99%
52-week Low
Aug 20, 2024 - $0.0132
52-week High
Apr 03, 2024 - $2.40
Valuation
Market Cap
-- - --
Enterprise Value
--
Price/Sales (TTM)
0.00
Price/Book (Q)
0.00
Dividends and Shares
Shares Outstanding
1.24M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.acorda.com
Phone Number
914 347 4300
Address
2 Blue Hill Plaza
Pearl River, NY 10965
Country
United States
Year Founded
1995
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral... more
Weiss Ratings